Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension

BACKGROUND: Vildagliptin, a DPP-4 inhibitor widely used for the treatment of type 2 diabetes mellitus (T2DM), shows beneficial effects on endothelial function. This study aims to evaluate the effect of vildagliptin on endothelial function and arterial stiffness in patients with T2DM and hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosenso-Martin, Luciana Neves, Giollo-Júnior, Luiz Tadeu, Martineli, Débora Dada, Cesarino, Cláudia Bernardi, Nakazone, Marcelo Arruda, Cipullo, José Paulo, Vilela-Martin, José Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550051/
https://www.ncbi.nlm.nih.gov/pubmed/26312070
http://dx.doi.org/10.1186/s13098-015-0062-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550051/
https://www.ncbi.nlm.nih.gov/pubmed/26312070
http://dx.doi.org/10.1186/s13098-015-0062-z

Ejemplares similares